1,524
Registered trials
675
Recruiting
694
Completed trials
369
Sponsors active
131
Research sites
Phase III:
630
Phase II/III:
59
Phase II:
394
Phase I/II:
84
Phase III/IV:
40
Phase IV:
174
Phase I:
53
Phase I (Other):
48
Phase I (FiH):
42
Oversight events in trials active here:
73 serious breaches
316 temporary halts
17 urgent safety measures
26 unexpected events
55 corrective measures
across 176 trials
View oversight register →
Top conditions
Non-small cell lung cancer
23
Ovarian cancer
14
Chronic kidney disease
13
Chronic obstructive pulmonary disease
12
Colorectal cancer
10
Endometrial cancer
10
Diffuse large B-cell lymphoma
9
Crohn's disease
9
Pulmonary arterial hypertension
9
Gastric cancer
8
Obesity
8
Idiopathic pulmonary fibrosis
7
Top sponsors
Rigshospitalet
96
Merck Sharp & Dohme LLC
64
F. Hoffmann-La Roche AG
59
Region Midtjylland
59
AstraZeneca AB
57
Odense University Hospital
54
Novartis Pharma AG
47
Region Hovedstaden
45
Janssen - Cilag International
37
AbbVie Deutschland GmbH & Co. KG
31
Novo Nordisk A/S
31
Sanofi-Aventis Recherche & Developpement
28
Cities with most trials
All 64 cities →All trials — page 3
1,524 total-
Extension Study of ACT-EARLY Pending
-
TRALULALA-AZI Pending
-
The SGL-TX-PTDM study Pending
Showing 49–72 of 1,524 trials